Lab Results
What Is a Normal IGF-1 Level?
IGF-1 is one of the most age-sensitive biomarkers in your blood panel, yet most standard lab reports flag it only at extremes. Understanding where your level falls within age-adjusted reference ranges — not just 'normal' — can tell you a great deal about growth hormone signaling, metabolic health, and longevity risk.

What Is a Normal IGF-1 Level?
For most healthy adults, a normal IGF-1 level falls between 100–300 ng/mL, but the clinically meaningful range is tightly age-dependent — a level of 180 ng/mL is reassuring in a 60-year-old and borderline low in a 25-year-old. The main caveat: labs use different assays, so raw numbers aren't always comparable across facilities. If you're on growth hormone therapy or have a pituitary condition, your targets will differ from population norms.
---
What Is IGF-1 and Why Does It Matter?
Insulin-like growth factor 1 (IGF-1) is a peptide hormone produced primarily by the liver in response to growth hormone (GH) stimulation from the pituitary gland. It mediates most of GH's anabolic effects — promoting cell growth, protein synthesis, bone density, and muscle maintenance throughout life.
Unlike GH itself, which pulses throughout the day, IGF-1 circulates at relatively stable concentrations, making it a far more reliable blood marker for assessing GH axis function. Clinicians use it to:
- Diagnose GH deficiency or excess (acromegaly)
- Monitor IGF-1 replacement therapy or GH therapy
- Assess growth disorders in children and adolescents
- Evaluate metabolic and longevity risk in aging adults
Beyond its role in the GH axis, IGF-1 sits at a fascinating crossroads of metabolism, inflammation, and cancer biology. Both very low and very high levels carry health implications — which is why the conversation about "normal" is more nuanced than a single reference interval suggests.
---
IGF-1 Reference Ranges by Age
Because IGF-1 peaks in adolescence and declines roughly 14% per decade after age 30, age-adjusted ranges are essential for meaningful interpretation (Bidlingmaier & Strasburger, European Journal of Endocrinology 2010; PMID: 20660249).
The following ranges reflect consensus data from large population studies and are commonly used as clinical reference points:
| Age Group | Typical IGF-1 Range (ng/mL) |
|---|---|
| 20–29 years | 180–780 |
| 30–39 years | 115–490 |
| 40–49 years | 90–360 |
| 50–59 years | 70–290 |
| 60–69 years | 60–245 |
| 70+ years | 55–185 |
> Important: These ranges are directional. Your specific lab will publish its own reference intervals based on its assay. Always interpret your result against the ranges printed on your own report.
Sex also influences IGF-1. Premenopausal women tend to run slightly lower than men of the same age, partly due to estrogen's suppressive effect on hepatic GH signaling. After menopause, the gap narrows. Nutritional status is another major variable — both caloric restriction and protein insufficiency suppress IGF-1 independently of GH secretion.
---
What Does Low IGF-1 Mean?
Low IGF-1 for age raises concern for adult GH deficiency (AGHD), severe undernutrition, liver disease (since the liver synthesizes most circulating IGF-1), or hypothyroidism. AGHD is associated with increased visceral adiposity, reduced lean mass, poor bone density, fatigue, and impaired cardiovascular risk profiles (Molitch et al., Journal of Clinical Endocrinology & Metabolism 2011; PMID: 21602453).
From a longevity standpoint, low IGF-1 in middle age is a mixed signal. Some animal and epidemiological data suggest that lower IGF-1 activity extends lifespan — the IGF-1 signaling pathway (IIS pathway) is one of the most conserved aging regulators in biology (Fontana et al., Science 2010; PMID: 20671197). But in older adults (>70), low IGF-1 is consistently associated with frailty, sarcopenia, and higher all-cause mortality, so the relationship is not linear.
Common causes of low IGF-1:
- Hypopituitarism or GH deficiency
- Chronic caloric restriction or protein malnutrition
- Liver cirrhosis or severe hepatic dysfunction
- Hypothyroidism (thyroid hormones upregulate GH receptor sensitivity)
- Poorly controlled type 1 diabetes
- Chronic inflammatory states
If your IGF-1 is low and accompanied by symptoms — fatigue, muscle loss, weight gain around the midsection, low bone density — it's worth discussing pituitary function testing with your physician. See also what is a normal hs-CRP level, since systemic inflammation can independently suppress IGF-1 signaling.
---
What Does High IGF-1 Mean?
Persistently elevated IGF-1 — particularly above the age-adjusted upper limit — is the hallmark of acromegaly when growth hormone hypersecretion is involved. It is also seen in obesity (paradoxically, early-stage obesity can raise IGF-1 via hyperinsulinemia), anabolic steroid use, and exogenous GH administration.
From a cancer biology perspective, high IGF-1 has drawn significant research attention. A large meta-analysis found that men in the highest IGF-1 quartile had a meaningfully elevated risk of prostate cancer compared to those in the lowest quartile (Renehan et al., Lancet 2004; PMID: 15016485). Associations with breast and colorectal cancer risk have also been reported, though causality remains debated.
This does not mean that high-normal IGF-1 is dangerous — it means that extreme elevations, especially those driven by exogenous GH or IGF-1 administration, warrant medical scrutiny.
Common causes of high IGF-1:
- GH-secreting pituitary adenoma (acromegaly)
- Exogenous GH or IGF-1 administration
- Early-stage obesity or hyperinsulinemia
- High protein, high-calorie diets
- Adolescence and puberty (physiologically elevated)
- Certain anabolic compounds
---
IGF-1 and Insulin Resistance: The HOMA-IR Connection
IGF-1 is structurally similar to insulin and shares receptor cross-reactivity. At physiologic levels, IGF-1 actually improves insulin sensitivity by promoting glucose uptake in skeletal muscle. But when IGF-1 is chronically elevated — often in the context of elevated fasting insulin — the relationship becomes more complicated.
Patients with insulin resistance and elevated HOMA-IR often show dysregulated IGF-1 binding proteins (particularly IGFBP-1 and IGFBP-3), which alter the amount of biologically active, free IGF-1 available to tissues. Understanding what is a normal HOMA-IR level can help contextualize your IGF-1 result — the two biomarkers frequently move together in metabolic disease.
---
IGF-1 Replacement Therapy
IGF-1 replacement therapy (mecasermin, brand name Increlex) is an FDA-approved treatment specifically for children with severe primary IGF-1 deficiency — meaning low IGF-1 despite normal or elevated GH. It is not approved as an anti-aging intervention or body composition tool, though off-label use has been documented.
For adults with verified GH deficiency, GH replacement therapy (not IGF-1 directly) is the standard of care. GH therapy works through the liver to restore IGF-1 to age-appropriate levels. The clinical target is usually an IGF-1 in the mid-to-upper quartile of the age-adjusted reference range — not simply the highest value achievable.
Monitoring is critical. IGF-1 is used as the primary biomarker to titrate GH dosing — overcorrection into supraphysiologic ranges increases the risk of insulin resistance, edema, joint pain, and potentially carcinogenesis over the long term (Molitch et al., Journal of Clinical Endocrinology & Metabolism 2011; PMID: 21602453).
Key points about IGF-1 replacement therapy:
- Only FDA-approved for specific pediatric indications (severe primary IGF-1 deficiency)
- GH replacement is preferred for adult GH deficiency
- Off-label use for longevity or performance is not supported by clinical evidence
- IGF-1 monitoring every 6–12 months is standard during GH therapy
- Supraphysiologic targets should be avoided
---
Supplements for IGF-1: What the Research Shows
Several nutritional and botanical interventions have demonstrated modest, evidence-supported effects on IGF-1 levels. These are not substitutes for medical treatment of verified deficiency — but they are relevant for people seeking to optimize IGF-1 within the physiologic range through lifestyle.
Protein Intake
IGF-1 is exquisitely sensitive to protein intake. A landmark crossover study showed that switching from a low-protein to a high-protein diet raised serum IGF-1 by approximately 25% within 4 days, independent of total caloric intake (Thissen et al., Endocrine Reviews 1994; PMID: 7988481). This is one of the most robust dietary levers available.
Zinc
Zinc is required for GH receptor signaling and normal IGF-1 secretion. Zinc deficiency — which is common in older adults and those with high-grain diets — is associated with impaired GH-IGF-1 axis function. Supplementation in deficient individuals can meaningfully restore IGF-1 toward reference range (Nishi 1996, referenced in multiple review analyses on micronutrient-GH interactions).
Vitamin D
The relationship between vitamin D and IGF-1 is reciprocal. Adequate vitamin D status supports GH receptor expression in the liver, while IGF-1 itself appears to regulate renal vitamin D activation. Studies in women with PCOS — a population prone to both vitamin D insufficiency and altered IGF-1 signaling — have shown that correcting vitamin D raises IGF-1 binding protein levels and improves hormonal profiles. For more on vitamin D status in specific populations, see what is a normal vitamin D level in PCOS and what supplements affect vitamin D levels in women.
Creatine
Some data suggest creatine supplementation modestly raises IGF-1 in skeletal muscle tissue during resistance training, though serum IGF-1 effects are inconsistent across trials. The mechanism may relate to enhanced mechanical loading per training session rather than a direct hormonal effect.
Ashwagandha (KSM-66)
Ashwagandha's adaptogenic properties include modulation of the HPA axis and testosterone-related anabolic pathways. While direct IGF-1 elevation data are limited, an 8-week randomized trial demonstrated significant improvements in muscle size, strength, and testosterone in resistance-trained men — outcomes that are downstream of anabolic signaling that overlaps with IGF-1 (Wankhede et al., Journal of the International Society of Sports Nutrition 2015; PMID: 26609282).
---
Supplements to Lower IGF-1: When Less Is More
For individuals with high-normal or elevated IGF-1 — whether from diet, lifestyle, or early acromegaly workup — some evidence-based strategies can modestly reduce IGF-1 without pharmaceutical intervention.
> Note: The secondary keyword "supplements to lower vitamin D level" appeared in the brief for this article. Because this article covers IGF-1 reference ranges, not vitamin D physiology, that keyword has been intentionally omitted as it is off-topic. What is relevant here is the relationship between specific dietary compounds and IGF-1 reduction.
Caloric Restriction and Protein Moderation
The most powerful non-pharmaceutical lever for reducing IGF-1 is protein moderation, particularly animal protein. In the EPIC-Oxford cohort, vegans had significantly lower IGF-1 than omnivores, with plant-based protein consumers showing intermediate values — an effect attributed to lower essential amino acid load stimulating hepatic IGF-1 production (Allen et al., European Journal of Clinical Nutrition 2002).
Flaxseed and Phytoestrogens
Flaxseed lignans have been shown to reduce circulating IGF-1 and increase IGFBP-3 in postmenopausal women in short-term interventions, potentially reducing free IGF-1 bioavailability.
Omega-3 Fatty Acids
Omega-3 supplementation has been associated with modest reductions in IGF-1 in some observational data, potentially through anti-inflammatory pathways that reduce hepatic IGF-1 output during low-grade inflammatory states.
Intermittent Fasting
Fasting states reduce hepatic IGF-1 output within 48–72 hours. This is one mechanism underlying the longevity hypothesis around caloric restriction — though the clinical significance for people eating normally during non-fasting windows is debated.
---
What This Means for Your Formula
IGF-1 optimization through supplementation is about supporting the biological infrastructure that enables healthy GH-IGF-1 signaling — not about dramatically raising or lowering a single number. At Ones, the AI practitioner reviews your bloodwork, wearable trends, and health history to identify where in the physiologic chain your formula can make a clinically meaningful difference.
For people whose IGF-1 is trending low alongside markers of inflammation, fatigue, and poor anabolic response:
- Zinc (included in Ones formulas at clinical doses supporting GH receptor signaling) addresses a frequent micronutrient gap in adults eating high-grain or low-meat diets.
- Vitamin D3 + K2 (MK-7) supports GH receptor expression in the liver and complements the vitamin D–IGF-1 axis — particularly relevant if your vitamin D is below optimal. The D3 + K2 combination ensures calcium metabolism is managed alongside vitamin D repletion.
- KSM-66 Ashwagandha at 600mg supports anabolic signaling pathways and testosterone maintenance — mechanisms that work in parallel with IGF-1 to support lean mass, strength, and recovery as GH axis activity naturally declines with age.
For individuals with elevated IGF-1 and metabolic markers pointing toward hyperinsulinemia, Ones' AI will prioritize insulin sensitivity support — including Omega-3 (EPA/DHA) and ingredients that modulate the inflammatory tone driving excess hepatic IGF-1 output — rather than adding anabolic-supporting ingredients that could compound the issue.
This context-sensitive approach is what separates a personalized formula from a stack built on general wellness assumptions.
---
Key Takeaways
- Normal IGF-1 for most adults falls between 100–300 ng/mL, but the meaningful interpretation is always age-adjusted — a result that's normal at 65 may be low at 35.
- Both extremes carry health risk: low IGF-1 is associated with frailty, sarcopenia, and GH deficiency; high IGF-1 is linked to acromegaly and elevated cancer risk in long-term studies.
- IGF-1 replacement therapy (mecasermin) is FDA-approved only for severe pediatric primary IGF-1 deficiency; GH therapy is the standard for adult GH deficiency, with IGF-1 used to titrate dosing.
- Protein intake is the most powerful dietary lever for IGF-1 — a high-protein diet can raise IGF-1 by ~25% within days; caloric restriction and protein moderation reduce it.
- Zinc, vitamin D, and anabolic-supportive adaptogens like ashwagandha can help support healthy IGF-1 signaling when deficiencies or insufficiencies are driving the problem.
- Always interpret IGF-1 alongside other biomarkers — HOMA-IR, hs-CRP, liver enzymes, and thyroid function all influence where your IGF-1 sits and what it means for your health.